Clinical Resource Materials for BD Neonatal Products

Clinical resource materials enhance knowledge and assist clinicians in optimizing patient care and reducing catheter-related complications.

• Frey, A.M., PICC complications in neonates & children. JVAD, Spring 1999.
• Pettit, J. Advances in Neonatal Care - Assessment of infants with peripherally inserted central catheters: part 2. Detecting less frequently occurring complications. NANN, Vol.3 - Number 1, February 2003, pgs. 14-26
• NAVAN Position Statement. Tip location of Peripherally Inserted Catheters. JVAD, Summer 1998.
• Vesely, T., Stranz, M., Masoorli, S., Hadaway, L., The diverse and conflicting standards and practices in infusion therapy. JVAD, Fall 2002.
• Pettit, J., Hughes, K. Neonatal Intravenous Therapy Practices. JVAD, Spring 1999, pgs. 7-16.
• Pettit, J. Challenges to providing vascular access in neonatal patients. JVAD, Spring 2000, pgs. 16-21.
• Pettit, J. Advances in Neonatal Care - Assessment of the infant with a peripheral intravenous device. NANN, Vol.3 - Number 5, October 2003, pgs. 230-240
• Mendelson, M.H., et al. Abstract Summary: Evaluation of a Safety IV Catheter (Insyte Autoguard, Becton Dickinson) using the Centers for Disease Control and Prevention (CDC) National Surveillance Systems for Hospital Healthcare Workers Database. Mount Sinai Med Center, New York, NY.
• Stanley M., Meister E., Fuschuber K., Infiltration During Intravenous Therapy in Neonates: Comparison of Teflon® and Vialon™ catheters. Southern Medical Journal, September 1992, Vol. 85, No. 9, pgs. 883-886.
• Maki, D. & Ringer, M. Risk Factors for Infusion-related Phlebitis with Small Peripheral Venous Catheters. Annals of Internal Medicine, Vol. 114, No. 10, 15 May 1991.
• Neonatal IV Therapy Points to Consider

Web Links

• Association Vascular Access
• BD Healthcare Workers Safety Site
• Centers for Disease Control and Prevention
• Intravenous Nurses Society
• National Association Neonatal Nurses
• National Institutes of Health
• Neonatal Network
• Occupational Exposure to Bloodborne Pathogens; Needlesticks and Other Sharps Injuries; Final Rule

Frey, A.M. PICC Complications in neonates & children. JVAD, Spring 1999. Order #J1999-1

"Since the 1960's, PICCs have served the neonatal and pediatric populations well as a venous access device that fits the niche between peripheral IV access and long-term central catheters. PICCs can be placed in children using a variety of methods, and can dwell indefinitely. As more PICC outcome data is reported, we note that PICC usage in neonates and children is not without complication, some of which can be severe or fatal." To receive a complimentary copy of the complete article #J1999-1, send an email to infusion_marketing@bd.com or call 1-800-227-2918.

Top of page

Pettit, J. Advances in Neonatal Care - Assessment of infants with peripherally inserted central catheters: part 2. Detecting less frequently occurring complications. NANN, Vol.3 - Number 1, February 2003, pgs. 14-26 Order #N2003-2

"Peripherally inserted central catheters (PICCs) are frequently placed in neonates to optimize nutrition and provide stable infusions of critical medications in the central vascular system. PICCs have been associated with a number of device-specific complications that can manifest during insertion, while the line is indwelling, and/or after the removal of the line. The second article of this series emphasizes the importance of ongoing systematic assessment of PICCs for device-specific complications such as catheter migration, dislodgement, breakage, phlebitis, and thrombosis, as well as the life-threatening complications of pleural and pericardial effusion and tamponade. Each complication is described, along with a review of the etiology, a description of the presenting signs and symptoms, and key clinical interventions." To receive a complimentary copy of the complete article #N2003-2, send an email to infusion_marketing@bd.com or call 1-800-227-2918.

Top of page

NAVAN Position Statement. Tip Location of Peripherally Inserted Central Catheters. JVAD, Summer 1998. Order #J1998

"During the past decade, the use of peripherally inserted central catheters (PICCs) has increased significantly. This increase in clinical use and importance has prompted deviation from the original concept of the PICC being a central venous catheter. After careful consideration of the clinical research, the Board of Directors of the National Association of Vascular Access Networks (NAVAN) feels there is sufficient information to support the following position statement. Navan recommends that the most appropriate location for the tip of PICCs is the lower one-third of the superior vena cava (SVC) close to the junction of the SVC and the right atrium." To receive a complimentary copy of the complete article #J1998, send an email to infusion_marketing@bd.com or call 1-800-227-2918

Top of page

Vesely T., Stranz M., Masoorli S., Hadaway L., The diverse and conflicting standards and practices in infusion therapy. JVAD, Fall 2002. Order #MISC532

"Insertion and management of vascular access devices require safe and consistent methods, and yet we frequently see inconsistency among documents written to guide the care that we provide. Standards of practice and practice guidelines are written by several organizations and therefore have differing recommendations. These documents are used as the basis for developing internal standards with each facility, so confusion about many aspects of care may be the end result.This review of standards and practices focuses on tip positioning of central venous catheters, the pH and osmolality of IV medications and solutions being delivered via venous access devices, assessing the functioning of devices prior to infusion of solutions, and the evolution of evidence-based practice. To receive a complimentary copy of the complete article #MISC532, send an email to infusion_marketing@bd.com or call 1-800-227-2918

Top of page

Pettit, J., Hughes, K. Neonatal Intravenous Therapy Practices. JVAD, Spring 1999, pgs. 7-16.

"Variations in neonatal IV therapy practice are commonplace. It is imperative that all medical care providers become educated in intravenous therapy and vascular device options. Improvement in vascular access technology, with enhanced short-term catheter materials and peripherally inserted central catheters, may offer this vulnerable population additional options for vascular access, with fewer complications and prolonged catheter indwelling periods." To order reprints, contact the AVA office at 1-877-924-2821 or visit the AVA website at www.avainfo.org.

Top of page

Pettit, J. Challenges to providing vascular access in neonatal patients. JVAD, Spring 2000, pgs. 16-21. Order #555

"When you consider what the nursing staff does and needs to accomplish in a neonatal intensive care unit (NICU), everything is viewed as a challenge. One of the biggest challenges in the NICU is that there is little evidence to support what we are doing on a day-to-day basis to treat these patients. While our body of knowledge is growing every year, we tend to take what works for adults and then try and make it work for babies. Intravenous therapy is an important part of providing care for these infants, but there are a few "myths" about IV therapy that impact treatment of these patients. These myths concern device selection, use of appropriate IV medications and solutions, and removal of devices." To receive a complimentary copy of the complete article, contact your BD Sales Consultant and ask for order #555 or send an email to infusion_marketing@bd.com. If you do not know who your BD Sales Consultant is, please call 1-888-237-2762.

Top of page

Pettit, J. Advances in Neonatal Care - Assessment of the infant with a peripheral intravenous device. NANN, Vol.3 - Number 5, October 2003, pgs. 230-240 Order #N2003

"Inserting, monitoring, and maintaining peripheral venous access is an integral component of neonatal nursing care. Although complications associated with peripheral vascular devices are typically minor, some infants may experience life-threatening sequelae or serious and prolonged alterations in function. This article provides a review of the relevant anatomy and physiology of the peripheral venous system, techniques for maintaining catheter security, and guidelines for conducting a systematic physical assessment. The most commonly occurring complications, such as infiltration, phlebitis, and occlusion, are described. The etiology of the complications, signs and symptoms, and key evidence-based prevention strategies outlined." To receive a complimentary copy of the complete article #N2003, send an email to infusion_marketing@bd.com or call 1-800-227-2918.

Top of page

Stanley M., Meister E., Fuschuber K., Infiltration During Intravenous Therapy in Neonates: Comparison of Teflon® and Vialon™ Catheters. Southern Medical Journal, September 1992, Vol. 85, No. 9, pgs. 883-886. Order #MISC507

"Infiltration is a frequent complication of intravenous therapy using peripheral venous lines in neonatal patients. In a randomized trial of two catheter materials, Vialon (Becton Dickinson) and Teflon (DuPont), we studied 19 putative risk factors for infiltration, including 11 infusates, in 772 peripheral venous lines in patients aged 1 to 67 days. The multivariate models showed that Vialon catheter material reduced the risk of infiltration by 18% in the total sample and by 35% in the higher risk low-weight (< 1500 g) subsample." To receive a complimentary copy of the article above, contact your BD Sales Consultant and ask for Order #MISC507 or send an email to infusion_marketing@bd.com. If you do not know who your BD Sales Consultant is, please call 1-888-237-2762.

Top of page

Maki, D. & Ringer, M. Risk Factors for Infusion-related Phlebitis with Small Peripheral Venous Catheters. Annals of Internal Medicine, Vol. 114, No. 10, 15 May 1991. Order #543

"Multiple factors, including the infusate and the duration of cannulation, contribute to the development of infusion-related phlebitis. The use of peripheral intravenous catheters made of PEU-Vialon appears to pose the same risk for catheter-related infection as the use of catheters made of FEP-Teflon, and PEU-Vialon can permit longer cannulation with less risk for phlebitis." To receive a complimentary copy of the article above, contact your BD Sales Consultant and ask for Order #543 or send an email to infusion_marketing@bd.com. If you do not know who your BD Sales Consultant is, please call 1-888-237-2762.

BD Insyte-N Autoguard Features and Benefits
BD Introsyte-N Autoguard Features and Benefits